Reduced Sympathetic Neuronal Uptake (Uptake1) in a Genetic Model of Desoxycorticosterone-NaCl Hypertension (42005)

  • Lawrence R. Krakoff
  • , Drori Ben-Ishay
  • , Judith Mekler

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

The effect of desoxycorticosterone (DOC)-NaCl treatment upon sympathetic neuronal uptake of norepinephrine (uptake,) was evaluated in strains of hypertension-resistant (SBN) and -prone (SBH) rats. Uninephrectomized animals were given either a placebo pellet sc and tapwater (untreated) or a 25-mg DOC pellet and 1% NaCl. Four weeks later, tail systolic pressure was significantly higher in DOC-NaCl SBH, 183 ± 3 mm Hg, than SBN, 141 ± 2 (P < 0.01). [3H]Norepinephrine (NE) uptake was determined in heart slices of all four groups by incubation in Krebs buffer at 37°C for 20 min at several concentrations. Preliminary studies confirmed that this is a measure of uptake,. Heart slices of DOC-NaCl-treated SBN and SBH rats had significantly reduced NE uptake at concentrations of 10-80 nM (P < 0.01); there was no significant difference between SBN and SBH in this regard. Untreated SBH rats have been shown to have a defect in baroreflex regulation when normotensive. The results raise the possibility that the greater increase in arterial pressure caused by DOC-NaCl in SBH compared to SBN may be related to both the inborn difference in reflex function and an acquired reduction in inactivation of norepinephrine by sympathetic neuronal uptake.

Original languageEnglish
Pages (from-to)240-245
Number of pages6
JournalExperimental Biology and Medicine
Volume178
Issue number2
DOIs
StatePublished - Feb 1985
Externally publishedYes

Fingerprint

Dive into the research topics of 'Reduced Sympathetic Neuronal Uptake (Uptake1) in a Genetic Model of Desoxycorticosterone-NaCl Hypertension (42005)'. Together they form a unique fingerprint.

Cite this